3rd Annual Protein Formulation Development & Drug Delivery Forum
13th June 2012 — 15th June 2012

Decrypt the Message for Accelerating Biotherapeutic Drug Delivery

Key conference topics:

• Update with latest protein formulation strategies
• Accelerate commercialisation of your protein drug
• Learn about novel drug delivery techniques and nano technologies for sub-visible particles
• Understand expectations from regulators for protein formulation development
• Minimise costs and risks by excellent QbD and assessment workflow of formulation phases

Conference focus:

Biotherapeutics are not something new today. However developing a state-of-the- art formulion for protein drugs remains the top challenge for scientists and companies. The evolving positions of regulatory agencies of early submission of data make it even more difficult for protein scientists to develop robust formulations in a short period of time. Whilst pharmas and biotechs are confronted by budget cuts and product pipelines drying up, expanding biotherapeutic portfolio is inevitable and urgently needed.

Following the very successful series of marcus evans Protein Formulation Development forums, this 3rd annual will delve further into the subject. We will discuss the latest progress within the industry, understand regulators' expectations, and most importantly the advancement and relationships between drug delivery and protein formulation. Join us to accelerate your biotherapeutic development!

Conference speakers:

Bernardo Perez-Ramirez, Ph.D.
Senior Scientific Director, BioFormulations Development
Genzyme Corporation

Monica Adams
Associate Director of Formulation Development
Bristol-Myers Squibb

Dr. Roland Schmidt
Senior Group Leader, Late-Stage Pharmaceutical & Processing Development PTDE-PF
F. Hoffmann-La Roche AG

Patrick Garidel
Head of Pharmaceutical Basic Development
Boehringer Ingelheim

Vineet Kumar, PhD
Senior Res Scientist II, Preformulation (Biologics)
Abbott

Andrea Ji
Scientist Late Stage Pharmaceutical & Processing
Genetech

Ana Cerdeira
Principal Scientist, PDMS - Drug Product Technical Integrator
Johnson & Johnson

Martinus Capelle
Staff Scientist & Biopharmaceutical Project Manager
Therapeomic Inc.

Dr. Gbolahan Oladiran
Senior Scientist
GSK

Farnaz Esmaeili, Ph.D.
Formulation Scientist
Medimmune

Expected Number of Attendees

100-200

View Conference Website: 3rd Annual Protein Formulation Development & Drug Delivery Forum

Price of Attendance

n/a

Brochure

View Event Brochure

Location

Barcelona
Barcelona
Barcelona
Spain
Barcelona